Journal article icon

Journal article

Stereoselective Bacterial Metabolism of Antibiotics in Environmental Bacteria – A Novel Biochemical Workflow

Abstract:
Antibiotic residues can reach aquatic ecosystems through urban wastewater discharges, posing an ecotoxicological risk for aquatic organisms and favoring the development of bacterial resistance. To assess the emission rate and hazardousness of these compounds, it is important to carry out periodic chemical monitoring campaigns that provide information regarding the actual performance of wastewater treatment plants (WWTPs) and the potential impact of the treated wastewater in the aquatic environment. In this study, 18 of the most widely consumed antibiotics in Spain were determined by liquid chromatography-tandem mass spectrometry in both influent (IWW) and effluent wastewater (EWW) samples collected over four seasons along 2021–2022. Eleven antibiotics were detected in EWW with azithromycin, ciprofloxacin and levofloxacin showing the highest concentration levels (around 2 μg L−1 of azithromycin and 0.4 μg L−1 of quinolone compounds). Data showed that only 4 out of the 11 compounds were removed by more than 50 % in the WWTP, with sulfamethoxazole standing out with an average removal efficiency >80 %. The risk that treated water could pose to the aquatic environment was also assessed, with 6 compounds indicating a potential environmental risk by exceeding established ecotoxicological and resistance thresholds. Based on the risk assessment, the WWTP removal efficiency required to reduce such risk for antibiotics was estimated. In addition, pooled wastewater samples were screened by LC coupled to high resolution mass spectrometry with ion mobility separation, searching for metabolites and transformation products of the antibiotics investigated to widen future research. Studies like this are crucial to map the impact of antibiotic pollution and to provide the basis for designing water quality and risk prevention monitoring programs
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Role:
Author
ORCID:
0000-0003-1446-6744
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-6376-5121
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-6901-3203
More by this author
Role:
Author
ORCID:
0000-0002-6634-8443


More from this funder
Funder identifier:
10.13039/501100000266
Grant:
EP/N509589/1
EP/P028403/1
More from this funder
Funder identifier:
10.13039/100004325
More from this funder
Funder identifier:
10.13039/501100000270


Publisher:
Frontiers Media
Journal:
Frontiers in Microbiology More from this journal
Volume:
12
Pages:
562157-562157
Article number:
562157
Publication date:
2021-04-16
DOI:
EISSN:
1664-302X
ISSN:
1664-302X


Language:
English
Keywords:
Pubs id:
1279065
Local pid:
pubs:1279065
Source identifiers:
W3156818237
Deposit date:
2026-04-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP